Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Assets Average (2019 - 2025)

10x Genomics (TXG) has disclosed Assets Average for 7 consecutive years, with $1.0 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 11.44% to $1.0 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 billion through Dec 2025, up 11.44% year-over-year, with the annual reading at $980.0 million for FY2025, 4.05% up from the prior year.
  • Assets Average hit $1.0 billion in Q4 2025 for 10x Genomics, up from $1.0 billion in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $1.0 billion in Q4 2025 to a low of $911.0 million in Q1 2025.
  • Historically, Assets Average has averaged $974.7 million across 5 years, with a median of $976.6 million in 2021.
  • Biggest five-year swings in Assets Average: soared 61.89% in 2021 and later fell 7.58% in 2024.
  • Year by year, Assets Average stood at $1.0 billion in 2021, then grew by 0.79% to $1.0 billion in 2022, then fell by 5.51% to $956.8 million in 2023, then decreased by 2.99% to $928.2 million in 2024, then grew by 11.44% to $1.0 billion in 2025.
  • Business Quant data shows Assets Average for TXG at $1.0 billion in Q4 2025, $1.0 billion in Q3 2025, and $941.7 million in Q2 2025.